Polysomnography is type of test conducted to diagnose sleep disorders. Sleep study is conducted to diagnose various sleep disorder conditions such as sleep apnea, periodic limb movement disorder, Narcolepsy, REM(Rapid Eye Movement), sleep behavior disorder, unexplained chronic insomnia, and others. Obesity is associated with modification in several comorbidities, including sleep-related disorders. High incidence of obesity is also expected to aid in growth of the market. Furthermore, increasing prevalence of sleeping disorders in developing economies is also anticipated to drive the market growth of the market during the forecast period.
Market Dynamics
The sleep testing services market provides essential diagnostic solutions for individuals experiencing sleep disorders. Technological advancements have revolutionized sleep testing, making it more accessible and convenient with portable devices and wearable trackers. Sleep disorders, such as sleep apnea and insomnia, are increasingly prevalent, emphasizing the importance of accurate diagnosis. The market is supported by healthcare policies and regulations that recognize the significance of sleep health and provide insurance coverage for sleep testing. With a focus on improving overall well-being, the sleep testing services market continues to expand globally.
On June 27, 2023, Vivos Therapeutics Inc launched VivoScore, a home sleep apnea test powered by SleepImage technology. The device, FDA-cleared for diagnosing obstructive sleep apnea (OSA), consists of a single-sensor ring recorder and a mobile app with cloud-based algorithms. Vivos-trained dentists and healthcare providers can now access cost-effective clinical-grade diagnostic technology, enhancing the effectiveness of the Vivos System treatment.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook